상처치료기 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Wound Therapy Devices Market was valued at USD 3.5 billion in 2024 and is estimated to grow at a CAGR of 4.5% to reach USD 5.4 billion by 2034. The rise in chronic wound cases, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is one of the primary drivers of market expansion. These types of wounds typically take longer to heal and require specialized care, which opens significant opportunities for advanced wound therapy devices. The growing prevalence of conditions like diabetes, obesity, and vascular diseases has escalated the need for advanced technologies like negative pressure wound therapy (NPWT) and pressure relief systems that aid in wound healing and reduce complications.

Additionally, the aging global population faces increased challenges related to wound healing due to reduced skin elasticity, diminished circulation, and other age-related health conditions. The market for wound therapy devices is part of the broader medical device industry, focusing on the development, production, and distribution of devices designed to aid in the treatment and management of both acute and chronic wounds, including surgical wounds, burns, and traumatic injuries.

The negative pressure wound therapy (NPWT) segment led the market in 2024 with a substantial share of 36.2%. This therapy is particularly effective in treating chronic wounds, especially those caused by conditions such as diabetes, obesity, and vascular diseases. NPWT accelerates the healing process by removing excess fluids, reducing swelling, and improving blood flow to the affected tissue, making it particularly valuable for managing complex wounds. Its effectiveness in post-surgical wound care has also contributed to its growing use, as it helps to reduce the risk of infection and promotes faster healing of surgical wounds. As chronic diseases continue to rise, the demand for NPWT will continue to expand, making it a key segment within the wound therapy devices market.

The hospitals segment held a 54.2% share in 2024. Hospitals perform a wide range of surgical procedures, including orthopedic, cardiovascular, and general surgeries, each of which can result in wounds requiring advanced management. Wound therapy devices, particularly NPWT systems and specialized dressings, are critical in these settings to prevent complications like infections, delayed healing, and dehiscence. The demand for these devices is driven by the increasing number of surgeries being performed worldwide and the need for effective wound care to improve patient outcomes and reduce recovery times. Hospitals also have access to specialized resources, such as wound care teams and advanced medical equipment, which further support the use of these sophisticated devices.

U.S. Wound Therapy Devices Market is expected to reach USD 2.1 billion by 2034. This growth is driven by the high incidence of chronic conditions like diabetes and cardiovascular diseases, which lead to a growing number of non-healing wounds. The demand for advanced wound care technologies such as NPWT, oxygen therapy devices, and wound monitoring sensors is increasing, particularly in hospitals and specialized care centers. The U.S. healthcare infrastructure, with its extensive network of healthcare practitioners, specialists, and access to advanced medical technologies, facilitates the adoption of these devices, contributing to improved wound healing outcomes and better overall patient care.

Some of the leading companies operating in the Global Wound Therapy Devices Market include 3M, B. Braun, Cardinal Health, Medtronic, Medela, Integra LifeSciences, Coloplast, Smith & Nephew, Lohmann & Rauscher, Molnlycke Health Care, Paul Hartmann, DeRoyal Industries, MiMedx, Organogenesis, and Cardinal Health. To solidify their position in the wound therapy devices market, companies are prioritizing product innovation, focusing on developing advanced and more effective devices such as improved NPWT systems and multifunctional wound care solutions.

Strategic partnerships with hospitals, outpatient centers, and healthcare providers are essential for companies to ensure their devices reach broader markets and gain wider adoption. Companies are also investing in comprehensive training programs for healthcare professionals to ensure proper application and integration of their products. Additionally, businesses are expanding their portfolios by introducing new technologies like bioactive wound dressings and smart wound monitoring systems to enhance the overall wound healing process.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Application
  • 2.2.4 End Use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic wounds
    • 3.2.1.2 Growing aging population
    • 3.2.1.3 Advancements in wound care technologies
    • 3.2.1.4 Increased surgical procedures and trauma cases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced wound therapy devices
    • 3.2.2.2 Limited awareness and adoption in developing countries
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Price trends
  • 3.6.1 By region
  • 3.6.2 By product
• 3.7 Reimbursement scenario
  • 3.7.1 Impact of reimbursement policies on market growth
• 3.8 Future market trends
• 3.9 Consumer behaviour analysis
• 3.10 Patent analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Competitive market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Negative pressure wound therapy
• 5.3 Hyperbaric oxygen therapy
• 5.4 Electric stimulation devices
• 5.5 Pressure relief devices
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Wound Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Chronic wounds
• 6.3 Acute wounds

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Mexico
  • 8.5.2 Brazil
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Cardinal Health
• 9.3 Coloplast
• 9.4 ConvaTec
• 9.5 DeRoyal Industries
• 9.6 Integra LifeSciences
• 9.7 Lohmann & Rauscher
• 9.8 Medela
• 9.9 Medtronic
• 9.10 MiMedx
• 9.11 Molnlycke Health Care
• 9.12 Organogenesis
• 9.13 Paul Hartmann
• 9.14 Smith & Nephew
• 9.15 3M